GlassScriptPhysician profile
Kirby Plessala
NPI 1134211147
$1,252.64
in general payments reported to CMS, 2019-2025
27 companies · $92.87 in 2025
The $92.87 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $65.47 · 2021: $242 · 2022: $123 · 2023: $501 · 2024: $67.24 · 2025: $92.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623 · Education: $38.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.69 |
| Education | $38.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $187.55 | 2019-2025 | Mara Console, Stripper |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.84 | 2022-2023 | Trulance |
| Exeltis, USA INC. | $114.47 | 2019-2025 | Slynd |
| Abbvie INC. | $84.71 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $79.72 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $78.78 | 2023-2025 | |
| Pfizer INC. | $64.22 | 2019-2023 | |
| Applied Medical Resources Corporation | $58.92 | 2021 | |
| Mylan Pharmaceuticals INC. | $57.19 | 2021-2022 | |
| Aspira Women'S Health INC | $46.02 | 2021 | |
| Meditrina | $35.70 | 2022-2023 | |
| Exact Sciences Corporation | $34.68 | 2023-2024 | Cologuard Collection Kit |
| Ethicon US, LLC | $31.96 | 2019-2020 | |
| Shield Therapeutics INC | $29.43 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $28.64 | 2022-2023 | Myosure Tissue Removal Device |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $18.03 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.12 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.68 | 2021 | |
| Millicent US INC | $14.44 | 2025 | Intrarosa, Femring |
| Eisai INC. | $13.99 | 2020 | |
| Amgen INC. | $13.89 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.65 | 2019 | |
| Avion Pharmaceuticals | $13.21 | 2019 | |
| Smith+Nephew, INC. | $12.79 | 2021 | |
| Lupin INC. | $11.37 | 2019 | |
| Vivus LLC | $11.06 | 2020 | |
| Organon LLC | $3.58 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirby Plessala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.